Skip to content
MUG-Chor1
Tissue
Bone, sacrum
Disease
Sacral chordoma
Synonyms
MUG-CHOR1, MUGCHOR1, Medical University of Graz-Chordoma 1

Documents

MUG-Chor1

Cell line · Product number 305478

The MUG-Chor1 cell line is a well-characterized in vitro model derived from a recurrent sacrococcygeal chordoma in a Caucasian female patient. Chordomas a...

€420.00excl. tax and shipping
In stock
Lot
Recommended (freshest lot)
  • CoA
1

01General information

Description

The MUG-Chor1 cell line is a well-characterized in vitro model derived from a recurrent sacrococcygeal chordoma in a Caucasian female patient. Chordomas are rare, malignant tumors that arise from remnants of the notochord along the axial skeleton. MUG-Chor1 was established through mechanical and enzymatic disaggregation of the tumor tissue and cultured under optimized conditions to sustain its growth. The cell line retains the hallmark features of chordoma, including the expression of brachyury, a transcription factor essential for notochordal differentiation and a diagnostic marker for chordomas. Additionally, MUG-Chor1 expresses cytokeratins, EMA, vimentin, and S-100 proteins, further validating its chordoma origin.

Genetically, MUG-Chor1 mirrors the chromosomal and molecular alterations typical of chordomas, including gains at the brachyury (T) locus on chromosome 6q27 and losses at 9p24.3-p13.1, encompassing the CDKN2A/CDKN2B loci. It also demonstrates deletions at loci such as 10q25.2, which includes PTEN, and other regions associated with tumor progression. These genetic characteristics make MUG-Chor1 a valuable tool for studying chordoma biology and for evaluating therapeutic interventions.

The slow growth rate of MUG-Chor1, with a doubling time of 7-10 days, reflects the clinical behavior of chordomas, which are known for their indolent but locally aggressive nature. This cell line has been pivotal in preclinical research, including drug screening studies that have identified potential therapeutic agents, such as EGFR inhibitors. These inhibitors have demonstrated efficacy in reducing cell viability and tumor growth in chordoma models, underscoring the relevance of MUG-Chor1 for translational studies.

Tissue
Bone, sacrum
Disease
Sacral chordoma
Synonyms
  • MUG-CHOR1
  • MUGCHOR1
  • Medical University of Graz-Chordoma 1

02Classification

Organism
Human
Sex
Female
Growth properties
Adherent
Biosafety level
1

03Characteristics

Morphology
Mesenchymal-like

04Identifiers

Citation
MUG-Chor1 (Cytion catalog number 305478)
NCBI TaxID
9606
Cellosaurus
CVCL_9277

05Handling and culture

Culture medium
IMDM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 25 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 3.024 g/L NaHCO3 (Cytion article number 820800a)
Incubation atmosphere

37°C, 5% CO2, humidified atmosphere.

Supplements
Supplement the medium with 10% FBS
Dissociation reagent
Accutase
Thawing and culturing
  1. Confirm that the vial remains deeply frozen upon delivery, as cells are shipped on dry ice to maintain optimal temperatures during transit.

  2. Upon receipt, either store the cryovial immediately at temperatures below -150°C to ensure the preservation of cellular integrity, or proceed to step 3 if immediate culturing is required.

  3. For immediate culturing, swiftly thaw the vial by immersing it in a 37°C water bath with clean water and an antimicrobial agent, agitating gently for 40-60 seconds until a small ice clump remains.

  4. Perform all subsequent steps under sterile conditions in a flow hood, disinfecting the cryovial with 70% ethanol before opening.

  5. Carefully open the disinfected vial and transfer the cell suspension into a 15 ml centrifuge tube containing 8 ml of room-temperature culture medium, mixing gently.

  6. Centrifuge the mixture at 300 x g for 3 minutes to separate the cells and carefully discard the supernatant containing residual freezing medium.

  7. Gently resuspend the cell pellet in 10 ml of fresh culture medium. For adherent cells, divide the suspension between two T25 culture flasks; for suspension cultures, transfer all the medium into one T25 flask to promote effective cell interaction and growth.

  8. Adhere to established subculture protocols for continued growth and maintenance of the cell line, ensuring reliable experimental outcomes.

06Quality control and cryopreservation

Sterility

Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods.

To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections.

Freeze medium
As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress.
Storage conditions

For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen.

Shipping conditions

Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage.

07Donor

Donor age
57 years
Ethnicity
Unspecified